Associated Papers
Anemia-associated mutations disrupt the CDIN1-Codanin1 complex in inherited congenital dyserythropoietic anemia I (CDA-I) disease.
Stojaspal M et al.
The Febs Journal, 2026
Using Patient Feedback to Improve Treatment Outcomes for Patients with Congenital Dyserythropoietic Anaemia Type I Receiving Interferon Therapy.
Frey K et al.
Journal of Clinical Medicine, 2026
Ropeginterferon alfa-2b as a promising alternative to conventional interferon in CDA type 1: a case report of two siblings.
Yang TW et al.
Clinical and Experimental Medicine, 2025
Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene.
Méndez M et al.
Annals of Hematology, 2021
Characterization of Two Cases of Congenital Dyserythropoietic Anemia Type I Shed Light on the Uncharacterized C15orf41 Protein.
Russo R et al.
Frontiers in Physiology, 2019
Congenital dyserythropoietic anemia type 1: a case with novel compound heterozygous mutations in the C15orf41 gene.
Palmblad J et al.
American Journal of Hematology, 2018
Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a.
Rathe M et al.
Pediatric Blood & Cancer, 2018
Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.
Taylor JC et al.
Nature Genetics, 2015
Select a paper to view details